Trials / Completed
CompletedNCT00975455
Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
Phase 3 Study of Hematuria Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,400 (estimated)
- Sponsor
- Predictive Biosciences · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.
Conditions
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-11-01
- Completion
- 2011-01-01
- First posted
- 2009-09-11
- Last updated
- 2011-06-08
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00975455. Inclusion in this directory is not an endorsement.